Worth Asset Management’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Worth Asset Management’s Portfolio BBC Stock Details BBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$216K	Buy	+4,093	New	+$183K	0.07%	193

Other funds holding BBC

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Worth Asset Management's BBC Position: Q2 2026 in Review

Worth Asset Management opened a new position in Virtus Biotech Clinical Trials ETF (BBC) in Q2 2026: 4,093 shares worth $216K. The stake represents 0.07% of the portfolio and ranks #193 among its holdings.

2 funds tracked by Wall St. Rank hold BBC as of Q2 2026.

Worth Asset Management held 4,093 shares of Virtus Biotech Clinical Trials ETF worth $216K as of Q2 2026.
Virtus Biotech Clinical Trials ETF was a new Worth Asset Management position in Q2 2026.
Virtus Biotech Clinical Trials ETF made up 0.07% of Worth Asset Management's portfolio in Q2 2026, its #193 holding.
2 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q2 2026.

Based on Worth Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.